About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs


  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank


« USPTO Will Remain Open . . . for Now | Main | California Biosimilar Bill Aligns with BIO Principles on Biologic Substitution »

October 02, 2013


Interesting that you chose not to speak with anyone with who might differ with the GPhA on this.

Mr. Howard:

If you work with or know of any companies or organizations having differing viewpoints on this issue, and would kindly provide us with their statements or reports, we would be happy to post on those as well.

Thanks for reading,


The Biotechnology Industry Organization has been a vocal advocate for this important bill, as it a necessary measure to ensure that patients and doctors remain in control of their medical treatment as the market for complex biologics evolves over the next several years.
If you want more info, check this out: http://www.biotech-now.org/corporate/2013/09/ask-ca-governor-brown-to-sign-sb-598#

The comments to this entry are closed.

April 2024

Sun Mon Tue Wed Thu Fri Sat
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30